Luminus Management’s Ensco Rowan plc ESV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-8,888,707
Closed -$75.8M 140
2019
Q2
$75.8M Buy
8,888,707
+4,563,637
+106% +$52.7M 1.82% 17
2019
Q1
$68M Buy
4,325,070
+1,100,637
+34% +$19.2M 1.46% 24
2018
Q4
$45.9M Buy
3,224,433
+2,598,527
+415% +$67M 0.93% 34
2018
Q3
$21.1M Sell
625,906
-165,000
-21% -$4.72M 0.34% 56
2018
Q2
$23M Sell
790,906
-1,240,534
-61% -$30.4M 0.53% 47
2018
Q1
$35.7M Buy
2,031,440
+1,141,740
+128% +$25.2M 0.74% 36
2017
Q4
$21M Sell
889,700
-2,570,282
-74% -$57M 0.45% 51
2017
Q3
$82.6M Buy
3,459,982
+1,793,242
+108% +$35.8M 2.19% 13
2017
Q2
$34.4M Buy
1,666,740
+1,030,090
+162% +$29.6M 0.72% 44
2017
Q1
$22.8M Buy
+636,650
New +$25.8M 0.59% 43
2016
Q4
Sell
-479,361
Closed -$16.3M 178
2016
Q3
$16.3M Buy
479,361
+334,083
+230% +$11.4M 0.42% 51
2016
Q2
$5.64M Sell
145,278
-9,594
-6% -$399K 0.16% 90
2016
Q1
$6.42M Sell
154,872
-71,723
-32% -$2.93M 0.21% 77
2015
Q4
$13.9M Buy
226,595
+201,095
+789% +$13.1M 0.52% 50
2015
Q3
$1.44M Buy
+25,500
New +$1.76M 0.04% 113

Other funds holding ESV

Luminus Management's ESV Position: Q3 2019 in Review

Luminus Management sold out of Ensco Rowan plc (ESV) in Q3 2019, closing a stake of 8,888,707 shares — an estimated $75.8M sold.

Luminus Management first reported a position in ESV in Q3 2015 and held it in 15 quarters. The position peaked at $82.6M in Q3 2017. 8 funds tracked by Wall St. Rank hold ESV as of Q3 2019.

  • Luminus Management reported no remaining Ensco Rowan plc position as of Q3 2019 after selling out during the quarter.
  • Luminus Management sold 8,888,707 Ensco Rowan plc shares in Q3 2019, an estimated $75.8M.
  • Luminus Management first reported a position in Ensco Rowan plc in Q3 2015 and held it in 15 quarters.
  • Luminus Management's Ensco Rowan plc position peaked at $82.6M in Q3 2017.
  • 8 funds tracked by Wall St. Rank held Ensco Rowan plc as of Q3 2019.

Based on Luminus Management's 13F filing for Q3 2019, filed 14 Nov 2019.